A comprehensive view of novavax inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
US Patent Issued to Novavax on Jan. 3 for "Coronavirus vaccine formulations" (Maryland Inventors)
Published:
January 21, 2023
by U.S. Fed News
|
Patent Issued for Coronavirus vaccine formulations (USPTO 11541112)
Published:
January 20, 2023
by NewsRx COVID-19 Daily
|
Novavax Nuvaxovid COVID-19 vaccine approved in South Korea as an adult booster; the vaccine is authorized for use as an adult booster in more than 35 countries, with other countries recommending use of the vaccine as a booster dose
Published:
January 18, 2023
by PR Newswire
|
Health Canada grants Novavax’s COVID-19 vaccine booster expanded authorization for use in adults aged 18 and older
Published:
January 17, 2023
by Indian Pharma Industry: Policies
|
Intellectual Property India Publishes Patent Application for 'Coronavirus Vaccine Formulations' Filed by Novavax, Inc.
Published:
January 14, 2023
by India Government News
|
Ask us about our Health Care Sector market view
Trending Chart
Interactive chart with headline count